Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Bacitracin Methylenedisalicylate, Halofuginone Hydrobromide Patent Expiration


About Veterinary Bacitracin Methylenedisalicylate, Halofuginone Hydrobromide

Bacitracin Methylenedisalicylate, Halofuginone Hydrobromide is used in a drug marketed by 1 company: Huvepharma Eood.

Other drugs containing Bacitracin Methylenedisalicylate, Halofuginone Hydrobromide are: Bmd / stenorol .

Bacitracin Methylenedisalicylate, Halofuginone Hydrobromide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bacitracin Methylenedisalicylate, Halofuginone Hydrobromide Generic API Manufacturers

Given below is the list of companies who have filed for Bacitracin Methylenedisalicylate, Halofuginone Hydrobromide generic, along with the locations of their manufacturing plants worldwide.